Biomarkers and Diagnostics assesses the technical and market environment for the development and use of biomarkers and diagnostic tests. Focusing on opportunities, challenges and trends, we provide high-level insight into the major drivers and pitfalls of biomarker-based R&D and diagnostic marketplaces. These reports help you understand how novel technologies can best fit into your drug and/or diagnostic development strategy and identify potential collaboration opportunities so that you can put that strategy into action.
Cancer Cardiovascular Central Nervous System Infectious Disease Immune & Inflammatory Metabolic Disorder Pain Management Respiratory Disorders Genitourinary Gastrointestinal Other High-Interest Diseases
Register to receive the Round-Up with our latest offers!